$-0.31
(Market cap
$5,754 Mln
Recently Viewed
Clear AllMarket cap
$5,754 Mln
Revenue (TTM)
$1,037 Mln
P/E Ratio
37.4
P/B Ratio
4.4
Div. Yield
0.6 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
0.1 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
22.3
Debt to Equity
0.2
Book Value
$38.9
EPS
$4.8
Face value
--
Shares outstanding
32,025,392
CFO
$1,283.87 Mln
EBITDA
$1,594.15 Mln
Net Profit
$811.47 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Balchem Corporation (BCPC)
| 14.0 | 7.9 | 4.0 | 11.0 | 10.8 | 7.8 | 10.6 |
|
BSE Sensex
| -8.3 | 4.2 | -5.6 | -2.4 | 9.2 | 10.1 | 11.6 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
Balchem Corporation (BCPC)
| -5.9 | 9.5 | 21.8 | 46.9 | 14.0 | 30.4 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Balchem Corporation (BCPC)
|
174.9 | 5,753.7 | 1,037.2 | 154.9 | 20.2 | 12.9 | 37.4 | 4.4 |
| 16.1 | 1,832.0 | 2,321.0 | 183.0 | 13.8 | -- | 10.7 | 1.7 | |
| 37.8 | 2,427.2 | 3,090.0 | 155.7 | 8.6 | 9.8 | 15.9 | 1.5 | |
| 33.9 | 2,208.8 | 3,090.0 | 155.7 | 8.6 | 9.8 | 14.2 | 1.4 | |
| 61.3 | 9,460.3 | 6,135.9 | 62.8 | 5.2 | 1.4 | 152.8 | 2.1 | |
| 64.0 | 3,409.5 | 1,102.0 | 139.1 | 7.7 | 12.3 | 26.3 | 2.8 | |
| 33.7 | 8,067.9 | 18,497.6 | 1,082.4 | 9.0 | 27.3 | 7.5 | 2.2 | |
| 104.5 | 5,192.0 | 8,358.0 | 319.2 | 9.7 | 8.6 | 18.3 | 1.4 | |
| 5,822.1 | 5,547.4 | 9,746.0 | 496.0 | 3.0 | 10 | 11.3 | 1.1 | |
| 42.6 | 3,368.7 | 732.5 | 100.1 | 16.9 | 11 | 33.7 | 3.5 |
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It... operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey. Read more
Chairman, CEO & President
Mr. Theodore L. Harris
Chairman, CEO & President
Mr. Theodore L. Harris
Headquarters
Montvale, NJ
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Balchem Corporation (BCPC) is $174.86 (NASDAQ) as of 23-Apr-2026 13:36 EDT. Balchem Corporation (BCPC) has given a return of 10.77% in the last 3 years.
The P/E ratio of Balchem Corporation (BCPC) is 37.40 times as on 17-Apr-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
32.01
|
3.94
|
|
2024
|
41.29
|
4.61
|
|
2023
|
44.51
|
4.58
|
|
2022
|
37.55
|
4.22
|
|
2021
|
57.40
|
6.29
|
The 52-week high and low of Balchem Corporation (BCPC) are Rs 183.75 and Rs 139.17 as of 24-Apr-2026.
Balchem Corporation (BCPC) has a market capitalisation of $ 5,754 Mln as on 17-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Balchem Corporation (BCPC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.